These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6606930)

  • 41. Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol.
    Togha M; Malamiri RA; Rashidi-Ranjbar N; Asa S; Mahvelati F; Ashrafi MR
    Acta Neurol Belg; 2012 Mar; 112(1):51-5. PubMed ID: 22427290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
    Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J
    Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Propranolol in acute migraine: a controlled study.
    Fuller GN; Guiloff RJ
    Cephalalgia; 1990 Oct; 10(5):229-33. PubMed ID: 2272092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Observations on the efficacy of propranolol for the prophylaxis of migraine.
    Rosen JA
    Ann Neurol; 1983 Jan; 13(1):92-3. PubMed ID: 6338806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
    Ashtari F; Shaygannejad V; Akbari M
    Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Beta-blockers and migraine. Efficacy of time-release propranolol versus placebo].
    Pradalier A; Serratrice G; Collard M; Hirsch E; Feve J; Masson M; Masson C; Dry J; Koulikovsky G; Nguyen G
    Therapie; 1990; 45(5):441-5. PubMed ID: 2260046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis.
    Micieli G; Cavallini A; Marcheselli S; Mailland F; Ambrosoli L; Nappi G
    Int J Clin Pharmacol Ther; 2001 Apr; 39(4):144-51. PubMed ID: 11332869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of low-intensity acenocoumarol on frequency and severity of migraine attacks.
    Wammes-van der Heijden EA; Smidt MH; Tijssen CC; van't Hoff AR; Lenderink AW; Egberts AC
    Headache; 2005 Feb; 45(2):137-43. PubMed ID: 15705119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prophylactic propranolol in the treatment of headache.
    Palferman TG; Gibberd FB; Simmonds JP
    Br J Clin Pract; 1983 Jan; 37(1):28-9. PubMed ID: 6340710
    [No Abstract]   [Full Text] [Related]  

  • 50. Preventive treatment of migraine.
    Silberstein SD
    Rev Neurol Dis; 2005; 2(4):167-75. PubMed ID: 16622394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of propranolol on glyceryltrinitrate-induced headache and arterial response.
    Tvedskov JF; Thomsen LL; Thomsen LL; Iversen HK; Williams P; Gibson A; Jenkins K; Peck R; Olesen J
    Cephalalgia; 2004 Dec; 24(12):1076-87. PubMed ID: 15566422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.
    Cleland PG; Barnes D; Elrington GM; Loizou LA; Rawes GD
    Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine.
    Domingues RB; Silva AL; Domingues SA; Aquino CC; Kuster GW
    Arq Neuropsiquiatr; 2009 Dec; 67(4):973-7. PubMed ID: 20069203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Migraine prophylaxis. A comparison of propranolol and amitriptyline.
    Ziegler DK; Hurwitz A; Hassanein RS; Kodanaz HA; Preskorn SH; Mason J
    Arch Neurol; 1987 May; 44(5):486-9. PubMed ID: 3579659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
    Yaldo AZ; Wertz DA; Rupnow MF; Quimbo RM
    Clin Ther; 2008 Dec; 30(12):2452-60. PubMed ID: 19167603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
    Gerber WD; Schellenberg R; Thom M; Haufe C; Bölsche F; Wedekind W; Niederberger U; Soyka D
    Funct Neurol; 1995; 10(1):27-35. PubMed ID: 7649498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N alpha methyl histamine versus propranolol in migraine prophylaxis.
    Millán-Guerrero RO; Isais-Millán R; Guzmán-Chávez B; Castillo-Varela G
    Can J Neurol Sci; 2014 Mar; 41(2):233-8. PubMed ID: 24534036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of migraine with propranolol.
    Borgesen SE
    Postgrad Med J; 1976; 52 Suppl 4():163-5. PubMed ID: 787958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
    Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR
    Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.